-
4 Reasons To Like AMN Healthcare
Friday, November 17, 2017 - 11:01am | 374Read More...AMN Healthcare Services, Inc. (NYSE: AMN), a staffing company for health care firms, has managed to secure the top-notch rating from KeyBanc Capital Markets, with the positive sentiment premised on four factors. The Analyst KeyBanc analyst Jason Gurda initiated coverage of AMN Healthcare...
-
5 Key Reasons To Invest In Mednax
Monday, September 18, 2017 - 2:55pm | 496Read More...Giving five justifications for its analysis, KeyBanc Capital Markets upgraded shares of MEDNAX Inc (NYSE: MD). The rating on the shares goes from Sector Weight to Overweight, with the price target at $51. 1. Headwinds Expected To Normalize Analyst Jason Gurda believes operating headwinds are...
-
Tenet Healthcare Said To Be Exploring Sale: How Far Is Management Willing To Go?
Thursday, September 14, 2017 - 10:25am | 379Read More...Shares of Tenet Healthcare Corp (NYSE: THC) were trading higher by nearly 3 percent after Thursday's opening bell in reaction to reports that the company is exploring strategic alternatives, including a potential sale of itself. However, investors holding on to Tenet's stock under the assumption...
-
KeyBanc Cuts Adeptus Health's Price Target From $59 To $31
Wednesday, November 2, 2016 - 1:40pm | 202Read More...After reporting far worse-than-expected Q3 results and announcing that the company will be exploring various financial alternatives through Goldman Sachs, shares of Adeptus Health Inc (NYSE: ADPT) were trading more than 60 percent lower. While firms Bank of America and Jefferies have downgraded...
-
Community Health, Universal Health Ratings Slashed By KeyBanc's Gurda: Here's Why
Thursday, July 16, 2015 - 11:02am | 318Read More...In a report published Thursday, KeyBanc analyst Jason Gurda downgraded shares of Community Health Systems (NYSE: CYH) and Universal Health Services, Inc. (NYSE: UHS) to Sector Weight ratings from a previous Overweight rating. Community Health: ‘Prudent To Get Out' Gurda stated that...
-
UPDATE: KeyBanc Capital Markets Downgrades DaVita HealthCare Partners Inc On Balanced Risk/Reward
Wednesday, September 17, 2014 - 11:09am | 169Read More...In a report published Wednesday, KeyBanc Capital Markets analyst Jason Gurda downgraded the rating on DaVita HealthCare Partners Inc (NYSE: DVA) from Buy to Hold, and removed the $75.00 price target. In the report, KeyBanc Capital Markets noted, “We are downgrading shares of DaVita Healthcare...
-
UPDATE: KeyBanc Capital Markets Initiates Coverage on Envision Healthcare on Positive Outlook
Wednesday, December 18, 2013 - 11:59am | 164Read More...In a report published Wednesday, KeyBanc Capital Markets analyst Jason Gurda initiated coverage on Envision Healthcare (NYSE: EVHC) with a Buy rating and $40.00 price target. In the report, KeyBanc Capital Markets noted, “Expansion beyond emergency department (ED) staffing to include...
-
Leerink Swann Maintains Humana (HUM) Market Perform Rating
Tuesday, March 16, 2010 - 8:31am | 203Read More...Leerink Swann analysts Jason Gurda and Neil Bhalodkar maintained their Market Perform rating for shares of Humana Inc. (NYSE: HUM) with a 12-month valuation range of $56-$59. The analysts said that although Humana Inc. is likely to lose 5% of its PFFS members in 2011, it could also gain market...
